Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Acquisitions & Divestments: 2017-2019

Historic Change in Acquisitions & Divestments for Cogent Biosciences (COGT) over the last 2 years, with Jun 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Change in Acquisitions & Divestments rose 19.34% to $8.0 million in Q2 2019 from the same period last year, while for Jun 2019 it was $48.0 million, marking a year-over-year increase of 102.48%. This contributed to the annual value of $294.5 million for FY2024, which is 16.03% up from last year.
  • As of Q2 2019, Cogent Biosciences' Change in Acquisitions & Divestments stood at $8.0 million, which was down 46.66% from $15.0 million recorded in Q1 2019.
  • Over the past 5 years, Cogent Biosciences' Change in Acquisitions & Divestments peaked at $15.0 million during Q4 2018, and registered a low of $4.0 million during Q1 2017.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $6.3 million (2017), whereas its average is $8.2 million.
  • Data for Cogent Biosciences' Change in Acquisitions & Divestments shows a peak YoY skyrocketed of 200.00% (in 2018) over the last 5 years.
  • Over the past 3 years, Cogent Biosciences' Change in Acquisitions & Divestments (Quarterly) stood at $5.0 million in 2017, then soared by 200.00% to $15.0 million in 2018, then grew by 19.34% to $8.0 million in 2019.
  • Its Change in Acquisitions & Divestments was $8.0 million in Q2 2019, compared to $15.0 million in Q1 2019 and $15.0 million in Q4 2018.